NCT03832712 The Swedish Essential Tremor (SWEET) Trial
| NCT ID | NCT03832712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Essential Tremor |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2018-06-30 |
| Primary Completion | 2026-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2018-06-30 with a primary completion date of 2026-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the effect of deep brain stimulation (DBS) vs best medical treatment in essential tremor (ET) in a randomized, single-blinded controlled trial.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of ET, as decided by the movement disorder specialist; Substantial incapacity; Duration of symptoms \> 5 years; Age 18 - 75; unsatisfying effect from β-blockers, or be unable to tolerate the medical therapy. Exclusion Criteria: * Cognitive impairment; Co-morbidity or non-compliance likely to jeopardize the result or to confuse the evaluation; Normal surgical exclusion criteria.
Contact & Investigator
Patric Blomstedt, PhD
STUDY CHAIR
Umeå Universitet
Frequently Asked Questions
Who can join the NCT03832712 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Essential Tremor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03832712 currently recruiting?
Yes, NCT03832712 is actively recruiting participants. Contact the research team at annelouice.eriksson@vll.se for enrollment information.
Where is the NCT03832712 trial being conducted?
This trial is being conducted at Gothenburg, Sweden, Linköping, Sweden, Lund, Sweden, Stockholm, Sweden and 2 additional locations.
Who is sponsoring the NCT03832712 clinical trial?
NCT03832712 is sponsored by Karolinska Institutet. The principal investigator is Patric Blomstedt, PhD at Umeå Universitet. The trial plans to enroll 100 participants.